Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its effects by...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Therapeutic challenges in patients with multiple sclerosis and ankylosing spondylitis: A case series.

Multiple sclerosis and related disorders·2025
Same author

Correlations Between Rheology, In Situ Mucosal Retention and In Vivo Immunogenicity Reveal the Potential and Limitations of Mucoadhesive Excipients for Sublingual Vaccine Delivery.

Pharmaceutics·2025
Same author

Proinflammatory Effect of Mesenchymal Stem Cells From Patients With Multiple Sclerosis: Potential Modulation Targets.

Neurology(R) neuroimmunology & neuroinflammation·2025
Same author

Neuroprotective strategies in multiple sclerosis: a status update and emerging paradigms.

Expert review of neurotherapeutics·2025
Same author

White Matter Microstructural Alterations in Type 2 Diabetes: A Combined UK Biobank Study of Diffusion Tensor Imaging and Neurite Orientation Dispersion and Density Imaging.

Medicina (Kaunas, Lithuania)·2025
Same author

Assessing disability progression using the WHODAS 2.0 in multiple sclerosis: Investigating clinical and socio-demographic factors in a large longitudinal cohort study (TONiC-MS).

Multiple sclerosis and related disorders·2024

Related Experiment Video

Updated: Jun 20, 2026

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

Cannabinoids and experimental models of multiple sclerosis.

Ilona Kubajewska1, Cris S Constantinescu

  • 1Division of Clinical Neurology, University of Nottingham, Queen's Medical Centre, Nottingham NG72UH, UK.

Immunobiology
|September 22, 2009
PubMed
Summary

Cannabinoids show promise in treating neuroinflammatory diseases by regulating immune responses and promoting neuroprotection. Further research in experimental autoimmune encephalomyelitis (EAE) could lead to new therapies for conditions like multiple sclerosis (MS).

More Related Videos

Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues
08:47

Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues

Published on: May 8, 2016

Scoring Central Nervous System Inflammation, Demyelination, and Axon Injury in Experimental Autoimmune Encephalomyelitis
08:17

Scoring Central Nervous System Inflammation, Demyelination, and Axon Injury in Experimental Autoimmune Encephalomyelitis

Published on: February 23, 2024

Related Experiment Videos

Last Updated: Jun 20, 2026

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues
08:47

Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues

Published on: May 8, 2016

Scoring Central Nervous System Inflammation, Demyelination, and Axon Injury in Experimental Autoimmune Encephalomyelitis
08:17

Scoring Central Nervous System Inflammation, Demyelination, and Axon Injury in Experimental Autoimmune Encephalomyelitis

Published on: February 23, 2024

Area of Science:

  • Neuroimmunology
  • Neuropharmacology
  • Autoimmune Diseases

Background:

  • Neuroinflammation is central to autoimmune neurodegenerative diseases of the central nervous system (CNS).
  • Experimental autoimmune encephalomyelitis (EAE) is a key animal model for studying these conditions.
  • Cannabinoids modulate immune responses and offer neuroprotection, relevant to diseases like multiple sclerosis (MS).

Purpose of the Study:

  • To explore the role of cannabinoids in regulating immune responses within the CNS.
  • To investigate the neuroprotective and neuroregenerative potential of cannabinoids.
  • To understand cannabinoid-mediated mechanisms in EAE as a model for human neurodegenerative diseases.

Main Methods:

  • Utilizing the experimental autoimmune encephalomyelitis (EAE) model.
  • Investigating the immunomodulatory effects of cannabinoids on innate and adaptive immune responses.
  • Assessing the neuroprotective and neuroregenerative capacities of cannabinoids in the CNS.

Main Results:

  • Cannabinoids modulate inflammatory reactions in the CNS.
  • Cannabinoids demonstrate neuroprotective and neuroregenerative properties.
  • Findings in EAE suggest potential therapeutic mechanisms for human diseases.

Conclusions:

  • Cannabinoids play a significant role in regulating immune responses and maintaining CNS homeostasis.
  • Cannabinoid-based therapies hold potential for treating neuroinflammatory and neurodegenerative diseases.
  • Continued study of cannabinoids in EAE is crucial for developing novel therapeutic strategies for MS and related conditions.